Alphalipoprotein cholesterol levels in relation to acute myocardial infarction and its risk factors

References

• Albers J. J., Cheung M. C., Hazzard W. R. High-density lipoproteins in myocardial infarction survivors. Metabolism 1978; 27: 479
   PubMed Web of Science ®Google Scholar
• Armitage P. Statistical methods in medical research. Blackwells, London 1974
   Google Scholar
• Ballantyne D., Ballantyne F. C., Melville D. A., Morrison B. A., McKenna J. P. Changes in plasma lipids and lipoprotein concentrations following myocardial infarction. Eur. J. clin. Incest. 1979; 9(II): 2
   Google Scholar
• Ballantyne F. C., Ballantyne D., Morrison B. A., Melville D. A., McKenna J. P. Changes in plasma proteins following myocardial infarction. Eur. J. clin. Incest. 1979; 9(II): 2
   Google Scholar
• Barr D. P., Russ M. E., Eder H. A. Protein lipid relationships in human plasma. II. In atherosclerosis and related conditions. Am. J. Med. 1951; 11: 480
   PubMed Web of Science ®Google Scholar
• Bergstrand R., Vedin A., Wilhelmsson C., Wallin J., Wedel H., Wilhelmsen L. Myocardial infarction among men below age 40. Br. Heart J. 1978; 40: 783
   PubMedGoogle Scholar
• Bergstrand R., Vedin A., Wilhelmsson C. A population study of men below 40 years of age. In preparation.
   Google Scholar
• Burstein M., Samaille J. Nouvel method de separation et dosage des lipoprotein de faible densite. Ann. Biol. clin. 1959; 17: 23
   PubMedGoogle Scholar
• Carlson L. A., Ericsson M. Quantitative and qualitative serum lipoprotein analysis. Part 2. Studies in male survivors of myocardial infarction. Atherosclerosis 1975; 21: 435
   PubMed Web of Science ®Google Scholar
• Castelli W. P., Doyle J. T., Gordon T., Hames C. G., Hjortland M.C, Hulley S. B., Kagan A., Zukel W. J. HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study. Circulation 1977; 55: 767
   PubMed Web of Science ®Google Scholar
• Elmfeldt D., Wilhelmsen L., Tibblin G., Vedin A., Wilhelmsson C., Bengtsson C. Registration of myocardial infarction in the city of Göteborg, Sweden. A community study. J. chron. Dis. 1975; 28: 173
   PubMedGoogle Scholar
• Elmfeldt D., Wilhelmsen L., Tibblin G., Vedin Wilhelmsson A.C.-E., Bengtsson C. A postmyocardial infarction clinic in Göteborg, Sweden. A follow-up of MI patients in a specialized out-patient clinic. Acta med. scand. 1975; 197: 497
   PubMed Web of Science ®Google Scholar
• Eriksen J., Enger S. C. The effect of smoking on selected coronary heart disease risk factors in middle-aged men. Acta med. scand. 1978; 203: 27
   PubMedGoogle Scholar
• Garrison R. J., Kannel W. B., Feinlieb M., Castelli W. P., McNamara P. M., Padgett S. J. Cigarette smoking and HDL cholesterol: the Framingham offspring study. Atherosclerosis 1978; 30: 17
   PubMed Web of Science ®Google Scholar
• Goldbourt K., Medalie J. H. Characteristics of smokers, non-smokers and ex-smokers among 10,000 adult males in Israel. II. Physiologic, biochemical and genetic characteristics. Am. J. Epidemiol. 1977; 105: 75
   PubMed Web of Science ®Google Scholar
• Gordon T., Castelli W. P., Hjortland M. C., Kannel W. B., Dawber T. R. High density lipoprotein as a protective factor against coronary heart disease. Am. J. Med. 1977; 62: 707
   PubMed Web of Science ®Google Scholar
• Helgeland A., Hjermann I., Leren P. High-density lipoprotein cholesterol and antihypertensive drugs: the Oslo study. Br. med. J. 1978; ii: 403
   Google Scholar
• Kannel W. B., Gordon T. Early phases of coronary heart disease, J. Waldenström, T. Larsson, N. Ljungstedt. Skandia International Symposia, Stockholm 1973
   Google Scholar
• Klose S., Borner K. Enzymatische Bestimmung des Gesamtcholesterins mit dem Greiner Selective Analyzer (GSA-II). J. clin. Chem. clin. Biochem. 1977; 15: 121
   PubMedGoogle Scholar
• Lehtonen A., Viikari J. Serum triglycerides and cholesterol and serum high-density lipoprotein cholesterol in highly physically active men. Acta med. scand. 1978; 204: 111
   PubMedGoogle Scholar
• Leppanen V. Evaluation of the p-toluene-sulphonic acid method for quantitative determination of total cholesterol in serum. Scand. J. clin. Lab. Invest. 1956; 8: 201
   PubMed Web of Science ®Google Scholar
• Lopez-S. A., Vial R., Balart L., Arvoyave G. Effect of exercise and physical fitness on serum lipids and lipoproteins. Atherosclerosis 1974; 20: 1
   PubMed Web of Science ®Google Scholar
• McCall M., Elmfeldt D., Vedin A., Wilhelmsen L., Wilhelmsson C., Vedel H. Blood pressure and serum cholesterol before and after myocardial infarction. Acta med. scand., (in press)
   Google Scholar
• Miller G. J., Miller N. E. Plasma high-density-lipoprotein concentration and development of ischemic heart disease. Lancet 1975; i: 16
   Google Scholar
• Miller N. E., Förde O. H., Thelle D. S., Mjös O. D. The Tromsö heart study. High-density lipoprotein and coronary heart-disease: a prospective case-control study. Lancet 1977; i: 965
   Web of Science ®Google Scholar
• Nikkilä E. Studies on the lipid-protein relationships in normal and pathological sera and the effect of heparin on serum lipoproteins. Scand. J. clin. Lab. Invest. 1953; 5(suppl. 8)
   Google Scholar
• The Pooling Project Research Group. Relationship of blood pressure, serum cholesterol, smoking habits, relative body weight and ECG abnormalities to incidence of major coronary events: final report of pooling project. J. chron. Dis. 1978; 31: 201
   PubMedGoogle Scholar
• Ritland S., Blomhoff J. D., Enger S. C., Skrede S., Gjone E. The esterification of cholesterol in plasma after acute myocardial infarction. Scand. J. clin. Lab. Invest. 1975; 35: 181
   PubMedGoogle Scholar
• Rose G. A., Blackburn H. Cardiovascular surrey methods. World Health Organisation. 1965
   Google Scholar
• Rhoads G. G., Gulbrandsen C. L., Kagan A. Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men. New Engl. J. Med. 1976; 294: 293
   PubMed Web of Science ®Google Scholar
• Shaw J., England J. D., Hua A. A. Beta-blockers and plasma triglycerides. Br. med. J. 1978; i: 986
   Google Scholar
• Siegel S. Nonparametric statistics for behavioral sciences. McGraw-Hill, New York 1956
   Google Scholar
• Stamler J., Berkson D. M., Lindberg H. A. The Pathogenesis of Atherosclerosis, R. W. Wissler, J. C. Geer. Williams and Wilkins, Baltimore 1972
   Google Scholar
• Tanaka N., Sakaguchi S., Oshige K., Niimura T., Kanehisa T. Effect of chronic administration of propranolol on lipoprotein composition. Metabolism 1976; 25: 1071
   PubMed Web of Science ®Google Scholar
• Tibblin G., Cramér K. Serum lipids during the course of an acute myocardial infarction and one year afterwards. Acta med. scand. 1963; 174: 451
   PubMedGoogle Scholar
• Tibblin G. A population study of 50-year-old men. An analysis of the non-participation group. Acta med. scand. 1965; 178: 453
   PubMedGoogle Scholar
• Waal-Manning H. J., Simpson F. O. Beta-blockers and lipid metabolism. Br. med. J. 1977; ii: 705
   Google Scholar
• Wahlefeld A. W. Methods of Enzymatic Analysis2nd English ed., H.U. Bergmeyer. Academic Press, New Yorkand London 1974; 1831
   Google Scholar
• Wiklund O., Gustafson A., Wilhelmsen L. α-lipoprotein cholesterol in men after myocardial infarction compared with a population sample. Artery 1975; 1: 399
   Google Scholar
• Wiklund O., Gustafson A., Bergstrand R., Vedin A., Wilhelmsson C. High density lipoproteins and atherosclerosis, A. M. Gotto, N. E. Miller, M. F. Oliver. Biomedical Press Elsevier, North-Holland 1978; 127
   Google Scholar
• Wilhelmsen L., Wedel H., Tibblin G. Multivariate analysis of risk factors for coronary heart disease. Circulation 1973; 48: 950
   PubMed Web of Science ®Google Scholar
• Wilhelmsson C., Vedin J. A., Wilhelmsen L., Tibblin G., Werkö L. Reduction of sudden death after myocardial infarction by treatment with alprenolol. Lancet 1974; ii: 1157
   Google Scholar
• Williams P., Robinson D., Bailey A. High-density lipoprotein and coronary risk factors in normal men. Lancet 1979; i: 72
   Google Scholar